Arnuity Ellipta Asthma Inhaler can now be used even in children aged 5 years, says FDA


eMedinexus    27 May 2018

The US Food and Drug Administration (FDA) has expanded the use of the inhaled corticosteroid fluticasone furoate (Arnuity Ellipta, GlaxoSmithKline) as a once-daily asthma maintenance treatment for children as young as age 5 years.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.